Literature DB >> 32262533

Matrix metalloproteinase-sensitive hydrogel microparticles for pulmonary drug delivery of small molecule drugs or proteins.

Emilie Secret1, Kelsey E Crannell, Stefan J Kelly, Maria Villancio-Wolter, Jennifer S Andrew.   

Abstract

Hydrogel microparticles are particularly attractive for pulmonary drug delivery. Their size can be engineered for efficient delivery into the bronchi, where they subsequently swell, avoiding macrophage uptake. In this study, enzyme-responsive peptide functionalized poly(ethylene glycol) (PEG) based hydrogel microparticles were synthesized by an emulsion polymerization. Here, we demonstrate that these microparticles are nontoxic and demonstrated their viability as a drug carrier by studying the encapsulation and release of three types of drugs: a hydrophobic (dexamethasone), a hydrophilic (methylene blue) and a protein (horseradish peroxidase)-based drug. The release of each of these three drugs was studied in the presence of varying concentrations of matrix metalloproteinase (MMP). Each of the three types of drugs were able to be encapsulated in the microparticles, and we further showed that the protein is still functional after release.

Entities:  

Year:  2015        PMID: 32262533     DOI: 10.1039/c5tb00443h

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  4 in total

1.  Hydrogel microparticles for biomedical applications.

Authors:  Andrew C Daly; Lindsay Riley; Tatiana Segura; Jason A Burdick
Journal:  Nat Rev Mater       Date:  2019-11-07       Impact factor: 66.308

Review 2.  Engineered Microgels-Their Manufacturing and Biomedical Applications.

Authors:  Hamzah Alzanbaki; Manola Moretti; Charlotte A E Hauser
Journal:  Micromachines (Basel)       Date:  2021-01-01       Impact factor: 2.891

3.  Gigavalent Display of Proteins on Monodisperse Polyacrylamide Hydrogels as a Versatile Modular Platform for Functional Assays and Protein Engineering.

Authors:  Thomas Fryer; Joel David Rogers; Christopher Mellor; Timo N Kohler; Ralph Minter; Florian Hollfelder
Journal:  ACS Cent Sci       Date:  2022-08-01       Impact factor: 18.728

Review 4.  Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Linh D Do; Brianne G Hritz
Journal:  Cells       Date:  2020-05-25       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.